Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
MIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA)…
Immunity and Intellect: Manipal Hospital Hebbal Champions Senior Health with Spell Bee Competition and Adult Vaccination Awareness
BENGALURU, India, June 25, 2025 /PRNewswire/ -- India is now experiencing a rise…
